Detalhe da pesquisa
1.
Rucaparib or Physician's Choice in Metastatic Prostate Cancer.
N Engl J Med
; 388(8): 719-732, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795891
2.
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.
N Engl J Med
; 381(2): 121-131, 2019 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31157964
3.
Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study.
Lancet Oncol
; 14(8): 769-76, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23706985
4.
Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma.
Cancer Rep (Hoboken)
; 6(3): e1763, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517084
5.
Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement.
Can Urol Assoc J
; 17(5): E154-E163, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185210
6.
Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial.
Eur Urol
; 84(2): 156-163, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37179241
7.
Cancer Clinic Redesign: Opportunities for Resource Optimization.
Curr Oncol
; 29(6): 3983-3995, 2022 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35735427
8.
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP.
J Clin Oncol
; 40(8): 837-846, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34928708
9.
Active Surveillance in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System.
Clin Genitourin Cancer
; 19(6): 521-530, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158246
10.
Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) - an International mRCC Database Consortium (IMDC) analysis.
J Geriatr Oncol
; 12(5): 820-826, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33674246
11.
Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival.
JAMA Netw Open
; 4(1): e2021869, 2021 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33475752
12.
Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial.
Eur Urol
; 79(3): 334-338, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33461782
13.
Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy.
Eur Urol
; 80(3): 275-279, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34030924
14.
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial.
JAMA Oncol
; 6(11): 1751-1758, 2020 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32940628
15.
Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis.
CMAJ
; 180(11): E62-71, 2009 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-19407261
16.
The timing of docetaxel initiation in metastatic castrate-sensitive prostate cancer and the rate of chemotherapy-induced toxicity.
Med Oncol
; 36(2): 18, 2019 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30666463
17.
Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial.
J Clin Oncol
; 37(14): 1159-1168, 2019 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30860948
18.
Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219.
Lung Cancer
; 133: 48-55, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200828
19.
Kidney Cancer Research Network of Canada consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials.
Can Urol Assoc J
; 12(6): 173-180, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29877179
20.
First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience.
Can Urol Assoc J
; 11(3-4): 112-117, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28515811